In summary, the process by which STING can be pharmacologically inhibited shows the promise of STING-targeting treatments for autoinflammatory diseases such as CANDLE/PRAAS [64]. The gene discussed is STING1; the disease is proteosome-associated autoinflammatory syndrome.